Cite

HARVARD Citation

    Bauman, L. et al. (2020). Improved Population Pharmacokinetic Model for Predicting Optimized Infliximab Exposure in Pediatric Inflammatory Bowel Disease. Inflammatory bowel diseases. 26 (3), pp. 429-439. [Online]. 
  
Back to record